FBInvestor
Stocks / The Oncology Institute Inc
Institutional Ownership

The Oncology Institute Inc

CUSIP 68236X100COMTOIQ1 2026

13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
16.6%
Max % of class reported
Institutional Holders
110
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

12 filings · latest Jun 24, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jun 24, 2025Fog Ventures Investments, LLC13G/A913SEC
2Apr 23, 2025Ravi Sarin13D/A4.7%SEC
3Dec 6, 2024Fmr LLC13G/ASEC
4Jul 10, 2023Fmr LLC13G/A6.3%SEC
5Feb 9, 2023Fmr LLC13G/A16.6%SEC
6Feb 14, 2022Integrated Core Strategies (Us) LLC13G/A25.6KSEC
7Feb 14, 2022Citadel Advisors LLC13G/A0.1%SEC
8Feb 14, 2022Park West Asset Management LLC13G/A0.3%62.2KSEC
9Feb 10, 2022Davidson Kempner Partners13G/A0.0%3.0KSEC
10Dec 10, 2021Fmr LLC13G12.5%SEC

2 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for The Oncology Institute Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →